著書論文等- 佐藤 公雄 -
表示方法: 表示形式: 表示順:
[]:著書 []:論文 []:総説・解説記事
件数:286件
[2020]
1.[] Cyclophilin A as a biomarker for the therapeutic effect of balloon angioplasty in chronic thromboembolic pulmonary hypertension..[Journal of cardiology,75(4),(2020),415-423]Katsuya Kozu, Kimio Satoh, Tatsuo Aoki, Shunsuke Tatebe, Masanobu Miura, Saori Yamamoto, Nobuhiro Yaoita, Hideaki Suzuki, Toru Shimizu, Haruka Sato, Ryo Konno, Yosuke Terui, Kotaro Nochioka, Nobuhiro Kikuchi, Taijyu Satoh, Koichiro Sugimura, Satoshi Miyata, Hiroaki Shimokawa
10.1016/j.jjcc.2019.09.010
http://www.ncbi.nlm.nih.gov/pubmed/31615744
[2019]
2.[] Diagnostic and Prognostic Significance of Serum Levels of SeP (Selenoprotein P) in Patients With Pulmonary Hypertension..[Arteriosclerosis, thrombosis, and vascular biology,39(12),(2019),2553-2562]Nobuhiro Kikuchi, Kimio Satoh, Taijyu Satoh, Nobuhiro Yaoita, Mohammad Abdul Hai Siddique, Junichi Omura, Ryo Kurosawa, Masamichi Nogi, Shinichiro Sunamura, Satoshi Miyata, Hirofumi Misu, Yoshiro Saito, Hiroaki Shimokawa
10.1161/ATVBAHA.119.313267
http://www.ncbi.nlm.nih.gov/pubmed/31665907
3.[] Usefulness of ventilatory gas analysis for the non-invasive evaluation of the severity of chronic thromboembolic pulmonary hypertension..[Int J Cardiol.,296,(2019),149-154]Akizuki M, Sugimura K, Aoki T, Kakihana T, Tatebe S, Yamamoto S, Sato H, Satoh K, Shimokawa H, Kohzuki M.
10.1016/j.ijcard.2019.07.018
4.[] Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease..[Journal of the American Heart Association,8(23),(2019),e013716]Tomohiro Ohtsuki, Kimio Satoh, Toru Shimizu, Shohei Ikeda, Nobuhiro Kikuchi, Taijyu Satoh, Ryo Kurosawa, Masamichi Nogi, Shinichiro Sunamura, Nobuhiro Yaoita, Junichi Omura, Tatsuo Aoki, Shunsuke Tatebe, Koichiro Sugimura, Jun Takahashi, Satoshi Miyata, Hiroaki Shimokawa
10.1161/JAHA.119.013716
http://www.ncbi.nlm.nih.gov/pubmed/31752640
5.[] Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension: Novel Effects of an Old Drug..[Arteriosclerosis, thrombosis, and vascular biology,39(11),(2019),2367-2385]Mohammad Abdul Hai Siddique, Kimio Satoh, Ryo Kurosawa, Nobuhiro Kikuchi, Md Elias-Al-Mamun, Junichi Omura, Taijyu Satoh, Masamichi Nogi, Shinichiro Sunamura, Satoshi Miyata, Hirofumi Ueda, Hidetoshi Tokuyama, Hiroaki Shimokawa
10.1161/ATVBAHA.119.313309
http://www.ncbi.nlm.nih.gov/pubmed/31533472
6.[] Successful management of acute congestive heart failure by emergent caesarean section followed by adrenalectomy in a pregnant woman with Cushing's syndrome-induced cardiomyopathy..[Intern Med.,58,(2019),2819-2824]Sakota M, Tatebe S, Sugimura K, Aoki T, Yamamoto S, Sato H, Kikuchi N, Konno R, Terui Y, Satoh K, Tezuka Y, Morimoto R, Saito M, Kuniyoshi S, Shimokawa H.
10.2169/internalmedicine.2427-18
7.[] ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target..[Circulation research,125(10),(2019),884-906]Junichi Omura, Kimio Satoh, Nobuhiro Kikuchi, Taijyu Satoh, Ryo Kurosawa, Masamichi Nogi, Tomohiro Ohtsuki, Md Elias Al-Mamun, Mohammad Abdul Hai Siddique, Nobuhiro Yaoita, Shinichiro Sunamura, Satoshi Miyata, Yasushi Hoshikawa, Yoshinori Okada, Hiroaki Shimokawa
10.1161/CIRCRESAHA.119.315398
http://www.ncbi.nlm.nih.gov/pubmed/31556812
8.[] 慢性血栓塞栓性肺高血圧症の病因からみた治療の展望.[呼吸器ジャーナル『肺高血圧診療 ガイドラインとニース会議提言を紐解く』,67(4), (2019)]佐藤 公雄、下川 宏明.
9.[] Checkpoint kinase 1 promotes the development of pulmonary arterial hypertension..[Arteriosclerosis, Thrombosis, and Vascular Biology,39,(2019),1504-1506]Satoh K, Kikuchi N, Kurosawa R, Shimokawa H.
10.1161/ATVBAHA.119.312969
10.[] 肺動脈性肺高血圧症の新しい治療標的の発見とアカデミア創薬.[循環器専門医, (2019)]佐藤 公雄、下川 宏明.
11.[] Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension..[Respirology.,(2019)]Akizuki M, Sugimura K, Aoki T, Kakihana T, Tatebe S, Yamamoto S, Sato H, Satoh K, Shimokawa H, Kohzuki M.
10.1111/resp.13618
12.[] Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension..[Circulation research,125(3),(2019),309-327]Ryo Kurosawa, Kimio Satoh, Nobuhiro Kikuchi, Haruhisa Kikuchi, Daisuke Saigusa, Md Elias Al-Mamun, Mohammad A H Siddique, Junichi Omura, Taijyu Satoh, Shinichiro Sunamura, Masamichi Nogi, Kazuhiko Numano, Satoshi Miyata, Akira Uruno, Kuniyuki Kano, Yotaro Matsumoto, Takayuki Doi, Junken Aoki, Yoshiteru Oshima, Masayuki Yamamoto, Hiroaki Shimokawa
10.1161/CIRCRESAHA.119.315229
http://www.ncbi.nlm.nih.gov/pubmed/31195886
13.[] 肺動脈性肺高血圧症における新規病因タンパクに着目した治療薬開発.[日本臨牀,77(7), (2019)]佐藤 公雄、菊地 順裕、黒澤 亮、砂村慎一郎、下川 宏明.
14.[] Recent advances in the understanding of thrombosis..[Arteriosclerosis, Thrombosis, and Vascular Biology,39,(2019),e159-e165]Satoh K, Satoh T, Yaoita N, Shimokawa H.
10.1161/ATVBAHA.119.312003
15.[] Beneficial effects of imatinib in a patient with suspected pulmonary veno-occlusive disease..[Tohoku J Exp Med.,247,(2019),69-73]Sato H, Sugimura K, Miura M, Konno R, Kozu K, Yaoita N, Shimizu T, Yamamoto S, Aoki T, Tatebe S, Satoh K, Shimokawa H.
10.1620/tjem.247.69
16.[] Clinical diversity in patients with Anderson-Fabry Disease with the R301Q mutation..[Intern Med.,58,(2019),603-607]Yamamoto S, Nagasawa T, Sugimura K, Kanno A, Tatebe S, Aoki T, Sato H, Kozu K, Konno R, Nochioka K, Satoh K, Shimokawa H.
10.2169/internalmedicine.0959-18
17.[] Sirtuin 5 promotes ischemia/reperfusion-induced blood-brain barrier damage after stroke..[Int J Cardiol.,284,(2019),77-78]Satoh K, Shimokawa H.
10.1016/j.ijcard.2018.11.019
18.[] Important roles of endothelial caveolin-1 in endothelium-dependent hyperpolarization and ischemic angiogenesis in mice..[Am J Physiol Heart Circ Physiol.,316,(2019),H900-H910]Ito A, Shiroto T, Godo S, Saito H, Tanaka S, Ikumi Y, Kajitani S, Satoh K, Shimokawa H.
10.1152/ajpheart.00589.2018
19.[] Response to letter regarding article "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: A Possible Novel Therapeutic Target.".[Circulation,139(5),(2019),724-725]Kikuchi N, Satoh K, Saito Y, Shimokawa H.
10.1161/CIRCULATIONAHA.118.038479
20.[] Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease..[PloS one,14(11),(2019),e0225403]Ryo Konno, Shunsuke Tatebe, Koichiro Sugimura, Kimio Satoh, Tatsuo Aoki, Masanobu Miura, Hideaki Suzuki, Saori Yamamoto, Haruka Sato, Yosuke Terui, Satoshi Miyata, Osamu Adachi, Masato Kimura, Yoshikatsu Saiki, Hiroaki Shimokawa
10.1371/journal.pone.0225403
http://www.ncbi.nlm.nih.gov/pubmed/31743362
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [next]
戻るこのページのトップへ
copyright(c)2005 Tohoku University